Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Cerbelli

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Cell Death and Differentiation|November 22, 2025
MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancerSabrina Zema, Francesca Di Fazio, Maria Pelullo, et al.
Minerva Endocrinology|December 11, 2024
Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian studyRoberto Baldelli, Marta Franco, Valerio Renzelli, et al.
Journal of Translational Medicine|July 13, 2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy eraAndrea Botticelli, Giulia Pomati, Alessio Cirillo, et al.
Pathologica|April 9, 2026
<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
Tumori|September 20, 2023
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian surveyBruna Cerbelli, Alessio Cirillo, Giulia Pomati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
The Impact of Concordance Between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the Rome TrialAndrea Botticelli, Chiara Cremolini, Simone Scagnoli, et al.
Nature Medicine|September 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trialPaolo Marchetti, Giuseppe Curigliano, Mauro Biffoni, et al.
Cancer Cytopathology|February 24, 2025
InterobServer AgreeMent in Pd-l1 evaLuatIoN on cytoloGical samples-SAMPLING project: A multi-institutional, international studyGennaro Acanfora, Antonino Iaccarino, Bruna Cerbelli, et al.
Critical Reviews in Oncology/Hematology|August 18, 2023
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide surveyNicola Fusco, Mariia Ivanova, Chiara Frascarelli, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Cell Death and Differentiation|November 22, 2025
MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancerSabrina Zema, Francesca Di Fazio, Maria Pelullo, et al.
Minerva Endocrinology|December 11, 2024
Neuroendocrine neoplasms of the breast: a multicenter retrospective Italian studyRoberto Baldelli, Marta Franco, Valerio Renzelli, et al.
Journal of Translational Medicine|July 13, 2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy eraAndrea Botticelli, Giulia Pomati, Alessio Cirillo, et al.
Pathologica|April 9, 2026
<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needsEltjona Mane, Giulia Cursano, Konstantinos Venetis, et al.
Tumori|September 20, 2023
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian surveyBruna Cerbelli, Alessio Cirillo, Giulia Pomati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
The Impact of Concordance Between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the Rome TrialAndrea Botticelli, Chiara Cremolini, Simone Scagnoli, et al.
Nature Medicine|September 30, 2025
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trialPaolo Marchetti, Giuseppe Curigliano, Mauro Biffoni, et al.
Cancer Cytopathology|February 24, 2025
InterobServer AgreeMent in Pd-l1 evaLuatIoN on cytoloGical samples-SAMPLING project: A multi-institutional, international studyGennaro Acanfora, Antonino Iaccarino, Bruna Cerbelli, et al.
Critical Reviews in Oncology/Hematology|August 18, 2023
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide surveyNicola Fusco, Mariia Ivanova, Chiara Frascarelli, et al.
Pageof 10